Interestingly, overexpression of MEX-3B in melanoma cells can downregulate the expression of HLA-A2 by binding to the 3′ UTR of HLA-A, thereby, blocking the recognition and CD8+ CTL-mediated killing of tumor cells. Here, MEX3B is linked to neoplasm.